DUCRESSA gtt opht fl 5 ml

7680681650010 CH-68165 S01CA01 11.06.1.
DUCRESSA gtt opht fl 5 ml
DUCRESSA gtt opht fl 5 ml
DUCRESSA gtt opht fl 5 ml
1 / 3
google

Details

Product number
6816501
CPT
-
Packaging group
5
Unit
ml
Composition
levofloxacinum 5 mg ut levofloxacinum hemihydricum, dexamethasonum 1 mg ut dexamethasoni natrii phosphas, benzalkonii chloridi solutio 0.10 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dodecahydricus, natrii citras dihydricus, natrii hydroxidum aut acidum hydrochloridum dilutum ad pH, aqua ad iniectabile, ad solutionem pro 1 ml corresp. phosphas 4.01 mg.

Articles (1)

Ducressa 1 mg / mL & 5 mg / mL, collyre en solution
Augentropfen
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/08/2022
Patient information leaflet
Français
29/08/2022
Patient information leaflet
Italien
29/08/2022
Professional SmPC
Allemand
29/08/2022
Professional SmPC
Français
29/08/2022
Professional SmPC
Italien
29/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
0.1 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.01 MG Substance HBESI

Authorization holder

Santen SA

1202 Genève

Authorization information

Swissmedic authorization number
68165
Drug name
Ducressa, collyre en solution
Galenic form
AUL
ATC Code
S01CA01
Authorization status
Z
Dispensation category
A
First authorization
26/03/2021
Authorization expiration date
31/12/9999
IT number
11.06.1.
Domain
Human medicine

Packaging details

Description (FR)
DUCRESSA gtt opht fl 5 ml
Description (DE)
DUCRESSA Gtt Opht Fl 5 ml
Market launch
26/03/2021
Narcotic (BTM)
No